Cipher Pharmaceuticals Inc.
CPHR
CPHR was delisted on the 8th of December, 2016.
1 hedge funds and large institutions have $7.26M invested in Cipher Pharmaceuticals Inc. in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
28% less capital invested
Capital invested by funds: $10.1M → $7.26M (-$2.8M)
67% less funds holding
Funds holding: 3 → 1 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NEI
Northwest & Ethical Investments
Toronto,
Ontario, Canada
|
-$1.72M |
| 2 |
AIC
AWM Investment Company
New York
|
-$676K |
CPHR Hedge Fund Activity: Q1 2017 in Review
1 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q1 2017, worth a combined $7.26M — down 28% from $10.1M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CPHR and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Northwest & Ethical Investments, exiting entirely with an estimated $1.72M sold.
- 1 institutional investor held Cipher Pharmaceuticals Inc. (CPHR) as of Q1 2017, down from 3 in Q4 2016.
- Funds reported $7.26M of Cipher Pharmaceuticals Inc. stock for Q1 2017, down 28% quarter-over-quarter.
- 0 funds opened new Cipher Pharmaceuticals Inc. positions in Q1 2017 and 2 closed out, a net change of -2 holders.
- The largest Cipher Pharmaceuticals Inc. seller in Q1 2017 was Northwest & Ethical Investments, an estimated $1.72M sold.
Based on aggregated 13F filings for Q1 2017.